
Heart health is one of the biggest concerns for modern lifestyles. Diet and daily habits play a crucial role, and green tea — especially matcha — has been studied extensively for its cardiovascular benefits.
Rich in Catechins for Heart Protection
Matcha is high in catechins, particularly EGCG, which has been shown to reduce oxidative stress and inflammation, both major contributors to heart disease (Hodgson & Croft, 2010).
Supports Healthy Cholesterol Levels
Studies suggest green tea catechins can lower LDL (“bad”) cholesterol while maintaining or raising HDL (“good”) cholesterol (Maron et al., 2003). This balance is key for reducing the risk of atherosclerosis.
Blood Pressure Regulation
Regular tea consumption has been linked to modest reductions in blood pressure, likely due to catechin-induced improvements in vascular function (Nagao et al., 2007).
Antioxidants and Vascular Health
Catechins improve endothelial function — the ability of blood vessels to relax and contract properly (Ras et al., 2011). This reduces strain on the cardiovascular system and supports better circulation.
Matcha’s high concentration of catechins makes it a heart-friendly beverage when consumed regularly as part of a balanced lifestyle. From improving cholesterol to supporting vascular health, the science supports its role in cardiovascular protection.
At Forest Cloud, we provide premium matcha sourced to preserve its antioxidant potential, making every cup a small step towards better heart health.
References
-
Hodgson, J. M., & Croft, K. D. (2010). Tea flavonoids and cardiovascular health. Molecular Aspects of Medicine, 31(6), 495–502.
-
Maron, D. J., et al. (2003). Cholesterol-lowering effect of a theaflavin-enriched green tea extract: A randomized controlled trial. Archives of Internal Medicine, 163(12), 1448–1453.
-
Nagao, T., et al. (2007). Tea catechins improve blood pressure and endothelial dysfunction. Journal of Nutrition, 137(2), 379–384.
Ras, R. T., et al. (2011). Effects of green and black tea consumption on endothelial function: A systematic review. Current Pharmaceutical Design, 17(36), 3801–3810.